IFNAR2: Difference between revisions
CSV import |
CSV import |
||
| Line 41: | Line 41: | ||
[[Category:Proteins]] | [[Category:Proteins]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 14:29, 17 March 2025
Introduction[edit]
IFNAR2 (Interferon Alpha and Beta Receptor Subunit 2) is a protein that in humans is encoded by the IFNAR2 gene. It is a critical component of the interferon receptor complex, which plays a vital role in the immune response to viral infections and other immune challenges.
Structure[edit]
IFNAR2 is a transmembrane protein that is part of the type I interferon receptor complex. This complex is composed of two subunits: IFNAR1 and IFNAR2. The IFNAR2 subunit is responsible for binding to type I interferons, such as interferon alpha and interferon beta.
The IFNAR2 protein has several domains:
- An extracellular domain that binds to interferons.
- A transmembrane domain that anchors the protein in the cell membrane.
- An intracellular domain that interacts with signaling molecules.
Function[edit]
The primary function of IFNAR2 is to mediate the biological effects of type I interferons. Upon binding of interferons to IFNAR2, a conformational change occurs that allows the receptor to associate with the Janus kinase (JAK) family of tyrosine kinases. This association leads to the activation of the JAK-STAT signaling pathway, which is crucial for the transcription of interferon-stimulated genes (ISGs).
These ISGs are involved in:
- Antiviral defense
- Regulation of cell growth
- Modulation of the immune response
Clinical Significance[edit]
Mutations or dysregulation of IFNAR2 can lead to altered immune responses. For example, defects in IFNAR2 have been associated with increased susceptibility to viral infections and may play a role in autoimmune diseases.
IFNAR2 is also a target for therapeutic interventions. Drugs that modulate the activity of IFNAR2 are being investigated for the treatment of various conditions, including multiple sclerosis and certain types of cancer.
Research[edit]
Ongoing research is focused on understanding the detailed mechanisms of IFNAR2 signaling and its role in disease. Studies are also exploring the potential of IFNAR2 as a biomarker for disease prognosis and treatment response.
Also see[edit]
